Multiple Myeloma: Hematology Journal Club 3.0

This journal club was a scientific educational activity on identification of Lenalidomide refractory Multiple Myeloma patients using the IMWG criteria and Discuss CANDOR & MMY1001 trials.

1
Optimising Treatment for Lenalidomide Refactory/Exposed Multiple Myeloma Patients
28 minutes

Speaker: Dr. Amar Lal 

Affiliations: Consultant Hematologist, Tawam Hospital, Al Ain, United Arab Emirates

 

This presentation was part of a scientific educational activity on identification of Lenalidomide refractory Multiple Myeloma patients using the IMWG criteria and Discuss CANDOR & MMY1001 trials. 

2
Case Presentation : Relapsed/Refractory Multiple Myeloma – KCCC , Kuwait
22 minutes

Speaker: Ramesh Pandita

Affiliations: Consultant Hematologist/ Oncologist , KCCC , Kuwait

 

This presentation was part of a scientific educational activity on identification of Lenalidomide refractory Multiple Myeloma patients using the IMWG criteria and Discuss CANDOR & MMY1001 trials.

3
RRMM
18 minutes

Speaker: Husni Hateeti

Affiliations: Consultant Hematologist, SKMC - Abu Dhabi, United Arab Emirates

 

This presentation was part of a scientific educational activity on identification of Lenalidomide refractory Multiple Myeloma patients using the IMWG criteria and Discuss CANDOR & MMY1001 trials. 

4
Hematology Journal Club 3: Panel Discussion
37 minutes

A panel discussion that included Dr. Amar Lal, Dr. Ramesh Pandita, and Dr. Husni Hateeti. 

Add to Wishlist
Enrolled: 12 students
Duration: 106 minutes
Presentations: 4